Madrigal Pharmaceuticals
MDGL
MDGL
267 hedge funds and large institutions have $5.64B invested in Madrigal Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 86 increasing their positions, 79 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 79
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
1% less call options, than puts
Call options by funds: $372M | Put options by funds: $376M
Holders
267
Holding in Top 10
14
Calls
$372M
Puts
$376M
Top Buyers
| 1 | +$179M | |
| 2 | +$111M | |
| 3 | +$74.5M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$33.4M |
| 5 |
AC
Armistice Capital
New York
|
+$31.5M |
Top Sellers
| 1 | -$124M | |
| 2 | -$112M | |
| 3 | -$83.3M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$80.3M |
| 5 |
Jane Street
New York
|
-$51.2M |